Shanghai, China
4.6 30 Reviews
No. 2516, Changzhong Road, Jing'an District, Shanghai
Distance from Airport : 61 km
Distance from Railway Station : 23 km
Get priority response from GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital Center

The GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2018, the certified hospital is situated in Shanghai, China, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 300.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Expected Price: USD130000GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2018, the accredited hospital is based in Shanghai, China and has 300 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Expected Price: USD3000With advanced oncology infrastructure, GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2018, the accredited hospital is located in Shanghai, China, and has 300 beds.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.


Hematologist
Shanghai, China
40 Years of experience
USD650 for video consultation


Real experiences from patients who trusted MediGence for their healthcare journey.

